Actinium Pharmaceuticals (NYSE:ATNM) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of Actinium Pharmaceuticals (NYSE:ATNM – Free Report) from a hold rating to a sell rating in a report published on Thursday morning. Separately, HC Wainwright reissued a “buy” rating and set a $4.00 target price on shares of Actinium Pharmaceuticals in a research report on Tuesday, April 1st. One analyst has rated […]
StockNews.com lowered shares of Actinium Pharmaceuticals (NYSE:ATNM – Free Report) from a hold rating to a sell rating in a report published on Thursday morning. Separately, HC Wainwright reissued a “buy” rating and set a $4.00 target price on shares of Actinium Pharmaceuticals in a research report on Tuesday, April 1st. One analyst has rated […]